week 3 cardiovasular Flashcards

1
Q

Cardiac Enzymes

A

Troponin levels rise rapidly after myocardial infarction and are sensitive indicators of cardiac injury.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Brain Natriuretic Peptide (BNP)

A

Elevated levels indicate heart failure.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Electrolytes and Urea

A

imbalances can affect heart function and indicate kidney issues.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Electrocardiography (ECG)

A

A 12-lead ECG records electrical activity and identifies rhythm abnormalities; stress tests with an ECG can be performed to assess heart function during exercise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Echocardiography

A

A non-invasive ultrasound to assess heart structure and function; a transesophageal echocardiograms (TOE) provides detailed images of heart valves and chambers.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Coronary Angiography

A

An invasive procedure to visualise coronary arteries and identify blockages.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Cardiac Magnetic Resonance Imaging (CMRI)

A

An advanced imaging technique for assessing heart anatomy and function, particularly useful for ischemia and heart failure

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Coronary Artery Calcium Scoring

A

A CT scan method to quantify calcium deposits in coronary arteries, useful for assessing cardiovascular risk

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Lab tests for cardiac S&S

A
  • Cardiac enzymes
  • Myoglobin
  • Creatine kinase (CK)
  • Brain-type natriuretic peptide (heart failure)
  • Urea and electrolytes
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Exercise stress testing

A

Treadmill test
ECG, blood pressure and heart rate
Useful for the diagnosis of
* Coronary artery disease
* Post myocardial infarction risk stratification
* Exercise induced arrhythmia
* Nuclear stress test
* function of heart muscle heart
* assess damage to heart muscle following an MI
* determine extent of coronary stenosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Holter monitoring

A
  • Small, portable monitoring device
  • Continuous ECG while patient
    conducts normal daily activities
  • Used for suspected frequent rhythm
    abnormalities
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Chest X-ray

A

Information:
Size and configuration of heart and great vessels
Lung fields and vessels
Routine cardiac investigation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Coronary Artery Calcium Scoring

A
  • Most useful in those patients with intermediate risk of
    CVD
  • Result will either lower or raise the risk profile
  • Provide a change in management.
  • Potential clinical cardiovascular risk: low-, medium- or
    high-risk categories
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Coronary Artery Calcium Scoring +ves

A
  • Advantages: convenient, noninvasive
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Coronary Artery Calcium Scoring -ves

A

radiation, no intravenous contrast
medium, cannot show coronary artery anatomy or
pathology.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Cardiac Magnetic Resonance Imaging (MRI) assessment of what type of disease and egs

A

assessment of congenital disease
* assessment of tumour
* abnormality of thoracic aorta;
* assessment of myocardial perfusion and viability
* evaluation of infiltrative diseases
* assessment of diseases of pericardium
* exclusion of anomalous coronary origins
* quantification of cardiovascular shunts
* quantification of ventricular function.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Normal sinus rhythm:

A

Regular rhythm, rate between 60-100 bpm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Sinus bradycardia

A

Regular rhythm, rate <60 bpm (common in athletes or vagal stimulation)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Sinus tachycardia

A

egular rhythm, rate >100 bpm (caused by fever, exercise, stress, etc.).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Atrial flutter

A

“Saw-tooth” pattern, rapid atrial rate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Atrial fibrillation

A

Irregular rhythm with no distinct P waves.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Supraventricular tachycardia (SVT)

A

Rapid heartbeat originating above the ventricles.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

First-degree atrioventricular (AV) block

A

Prolonged PR interval (>0.20 sec), but each P wave conducts.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Second-degree AV block Mobitz Type I (Wenckebach)

A

Progressive PR interval prolongation before dropping a QRS complex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

Second-degree AV block Mobitz Type II:

A

Random QRS drops with consistent PR intervals.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Third-degree AV block:

A

Complete heart block; atria and ventricles beat independently.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Junctional rhythm:

A

Junctional rhythm: Narrow QRS, absent or inverted P waves, rate 40-60 bpm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Idioventricular rhythm

A

Wide QRS, no P waves, rate 20-40 bpm.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Ventricular tachycardia (VT)

A

Wide QRS, fast rate, can be life-threatening.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Ventricular fibrillation (VF)

A

Chaotic, no organized electrical activity; requires immediate defibrillation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

Torsades de pointes

A

A type of polymorphic VT, often caused by electrolyte imbalances.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

Pulseless Electrical Activity (PEA)

A

ECG activity without a pulse.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

Asystole

A

Flatline, no electrical activity, requires CPR.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

what is a p wave

A

The first, the small P wave, represents the depolarisation from the SA node through the atria. The first part of the P wave is flat and represents electrical impulse generation by the SA node

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

PR interval

A

The time the electrical impulse takes to travel from the SA node through to ventricular discharge. It is measured from the beginning of the P wave to the beginning of the QRS complex

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

QRS complex

A

This represents the time taken to depolarise both ventricles. It is a combination of three deflections visible on the ECG and should be sharp and narrow.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

ST segment

A

The period when the ventricles are depolarised. It connects the QRS complex and the T wave

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

T wave

A

the time taken to repolarise the ventricles. It is the final deflection visible on the ECG and should be upright.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

Triglycerides are used in

A

energy metabolism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

Lipoproteins

A
  • Package of insoluble lipids to be transported in blood
  • Cholesterol, triglycerides, phospholipids, and protein
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

Cholesterol production of

A

cell membranes, steroids and bile acid

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

Abnormal lipoprotein metabolism can be a

A
  • predisposing factor to
    atherosclerosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

HDL high-density lipoprotein

A
  • “GOOD” cholesterol
  • cholesterol from arterial walls to liver.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

LDL low-density lipoprotein

A
  • deposition of cholesterol in arterial walls for use
  • accumulates in sub-endothelial space
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

VLDL 5 very-low-density lipoprotein

A
  • triglycerides to cells for energy
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

Chylomicrons

A
  • largest, least-dense lipoprotein
  • transport dietary triglycerides and
    cholesterol from the intestinal epithelial cells to liver, skeletal muscle and adipose tissue
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

Aetiology of atherosclerosis (non-modifable factors)

A

risks inc
* Familial hypercholesterolaemia
* Age and gender (men ≥45 years; women ≥55 years)
* Type 1 Diabetes Mellitus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

Aetiology of atherosclerosis modifiable risk factors

A

HDL cholesterol <40 mg/dL
C-reactive Protein levels (CRP)
overweight and obese
diet high in salt and fatty foods
sedentary lifestyle

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

Pathogenesis of atherosclerosis

A

Formation of fibrofatty lesions in the intimal lining
- process that causes disease of the coronary, cerebral, and peripheral arteries and aorta
Types of lesions associated with atherosclerosis
* Fatty streaks
* Fibrous atheromatous plaque
* Complicated lesion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

Pathogenesis of atherosclerosis- 1. Endothelium dysfunction

A
  • active biologic interface between blood and tissues
  • risk factor effect
  • dysfunction due to loss of NO and microtears
  • leukocytes recruited and inflammatory process starts
51
Q

Pathogenesis of atherosclerosis- Endothelium inflammation

A
  • entry of circulating fat and cholesterol
  • oxidisation of LDLs
  • attracts circulating monocytes
    (become macrophages) to restore
    vessel wall integrity
  • inflammatory mediators released
  • smooth muscle cells grow and enter
  • macrophages and migrating smooth muscle cells consume ox-LDLs
52
Q

Pathogenesis of atherosclerosis- Oxidised LDL is cytotoxic at high levels

A
  • death of macrophages and smooth muscle cells
  • deposition of cell contents and cholesterol crystals
  • necrotic core forms in arterial wall
53
Q

Fibrous cap

A
  • fibrin infiltration (stiffening wall)
  • calcium deposition (hardening of vessel wall)
  • fibrous plaque with connective tissue and lipids
54
Q

Atherosclerotic plaque

A

Continues to grow and cause narrowing
of the vessel and production of ischemia

55
Q

“Stable” plaque

A

Small lipid pool with thick fibrous cap. and preserved lumen

56
Q

“Vulnerable” plaque

A
  • Large lipid pool, thin fibrous cap,
    many inflammatory cells
  • Can commonly rupture and cause a thrombus which can further lead to narrowing
57
Q

Progression of plaque

A
  • plaque cap splits
  • necrotic material traps platelets
  • thrombus formation
  • reduces size of or blocks artery lumen
  • limited NO to vasodilation
58
Q

Epidemiology of atherlosclerosis

A

Atherosclerosis can begin in childhood with the development of fatty streaks. The lesions of atherosclerosis advance with aging. As the aetiology of atherosclerosis is multifactorial, the epidemiology is related to risk factors

59
Q

acute clinical manifestations of atherlosclerosis

A

stroke, acutue coronary syndromes, aortic occlusion, aortic rupture, aortic dissection, renal artery occlusion, acute peripheral arterial occlusion, acute mesenteric ischemia

60
Q

clinical manifestations chronic presentation of atherloscleoris

A

recuurent transient ichemaemic attacks, stable angina, silent ischemia, aortic aneuryum and more

61
Q

Progression of atherosclerosis

A
  1. Endothelial Dysfunction and Inflammatory Cell Recruitment. atherosclerosis begins with endothelial injury
  2. Foam Cell Formation: The Inflammatory Amplification Cycle.
  3. Plaque Progression and Fibrous Cap Formation.
  4. Plaque Rupture: A thin fibrous cap
62
Q

what factors of increase ageing contributes to an increase Arteriosclerosis

A

The elastin is progressively replaced with stiffer collagen fibres
Increase in advanced glycation end-products

63
Q

Consequences of Age-Related Arterial Changes

A

hypertension (especially isolated systolic hypertension)
increases the load on the left ventricle, leading to hypertrophy, impaired relaxation and heart failure.
microvascular damage in organs

64
Q

Peripheral artery disease (PAD) mainly occurs in

A

legs and feet

64
Q

Peripheral artery disease (PAD) aeitology

A

usually from a thrombus.

65
Q

Peripheral artery disease (PAD) Epidemiology

A

affect approximately 20% of those aged 75 and over, and most people with PAD show no symptoms, leading to under-diagnosis and under-treatment.

66
Q

Peripheral artery disease (PAD) Pathogenesis common and less common causes of pad

A

most common cause of PAD is atherosclerosis
Less common causes of PAD include infection or inflammation of the artery and injury to the affected limb

67
Q

Thrombosis

A

Local formation of a blood clot within a diseased artery, typically due to atherosclerotic plaque rupture, which can rapidly occlude the artery. These commonly affect the femoral or popliteal arteries,

68
Q

Embolus

A

Often originating from cardiac sources emboli can travel and lodge in peripheral arteries, abruptly obstructing blood flow. They usually lodge in aortic, iliac, femoral and popliteal bifurcations.

69
Q
  1. Anaerobic Metabolism and Acidosis
A

Normally, cells produce ATP via aerobic respiration, using oxygen to break down glucose. When oxygen is unavailable (ischemia), cells shift to anaerobic glycolysis, producing lactic acid instead of ATP.

70
Q

Lactic acid accumulation → Tissue acidosis (↓ pH), which respults in

A

disrupts enzyme function
damages proteins and cell membranes

71
Q
  1. ATP Depletion and Ion Pump Failure
A

ATP is needed for ion pumps to maintain cell homeostasis. When ATP is depleted, two critical pumps fail Sodium-Potassium (Na⁺/K⁺) Pump Failure leading to swelling and Calcium (Ca²⁺) Pump Failure leading to an overload, triggering harmful enzymatic activity inside the cell which degrade vital cell components.

72
Q

High intracellular Ca²⁺ activates

A

Proteases – Break down muscle proteins (actin, myosin), leading to cell death.
Phospholipases – Degrade cell membranes, making them leaky.
Endonucleases – Damage DNA, contributing to irreversible injury.

73
Q
  1. Release of Cellular Contents into the Bloodstream
A

K+- Worsens metabolic acidosis and electrolyte imbalance
Creatine Kinase (CK)- marker of muscle damage, detected in blood tests
Myoglobin- Can clog kidney tubules, causing acute kidney injury (AKI) and dark urine (myoglobinuria

74
Q

Clinical manifestations of PAD

A

irregular pain during activity and rest
numbness, coldness or pins and needles in the affected body part
blue- or purple-tinged skin

75
Q

arterial obstruction clinical manifestations

A

reduced perfusion in peripheral tissues, ischemia and tissue necrosis

76
Q

Vasculitis

A

the presence of inflammatory leukocytes in vessel walls with reactive damage to mural structures…[which can lead to] tissue ischaemia and necrosis

77
Q

vasculitis Patient Presentation

A

joint pain (arthralgia), weakness or altered circulation in their hands or feet. Additionally, symptoms like dizziness or unequal pulses

78
Q

What implications does bradycardia have for physiotherapy treatment

A

dizziness and chest pain

79
Q

What distinguishes premature ventricular contractions (PVCs)?

A

Heartbeat initiated by the heart ventricles rather than the sinoatrial node

80
Q

Describe the pathway of electrical impulse conduction in the heart.

A

impulses generated @ SA node, travel through the AV node, bundle of His, bundle branches and to the Purkinje fibres in the ventricles

81
Q

primary function of the cardiac conduction system?

A

Control the rate and direction of electrical impulse conduction

82
Q

aimed values for total cholesterol, hdl, ldl, triglyercrides

A

total= 3.9-5.5 mmol/L
hdl- 1.7-3.5
ldl= 1.7-3.5
tri= 0.9-2.1

83
Q

what is an Aneurysms

A

an enlargement of an artery resulting in a diameter of more than 1.5 times the normal size

84
Q

Aetiology of aneurysm

A

a localised dilation or bulging of a blood vessel due to weakening of the arterial wall

85
Q

aneurysm risk factors

A
  • Congenital Factors: Connective tissue disorders
  • Degenerative Changes: Atherosclerosis,HTN, aging
  • Inflammatory and Infectious Causes: Vasculitis, autoimmune disorders
  • Trauma and Iatrogenic Causes: Blunt or penetrating trauma; surgical or endovascular interventions leading to pseudoaneurysm formation
  • Lifestyle and Environmental Factors: Tobacco smoking; dyslipidaemia, diet, being sedentary and the environment
86
Q

Epidemiology aneurysms

A

2–3% of the adult population may develop an aneurysm over their lifetime

87
Q

Aortic Aneursyms

A

Aortic aneurysm is the second most common disease affecting the aorta after atherosclerosis

88
Q

Thoracic Aortic Aneurysm (TAA)

A

Occurs in the upper part of the aorta. The majority (~95%) of patients are asymptomatic until a serious event, such as aortic dissection or rupture, occurs

89
Q

Abdominal Aortic Aneurysm (AAA):

A

Defined as a localised enlargement of the abdominal aorta to a diameter of ≥30 mm (on abdominal US or CT) and are a degenerative disease of ageing. Approximately 4–7% of men and 1–2% of women over the age of 65 are affected.

90
Q

Cerebral Aneurysms (CA)

A

Defined as dilations that occur at weak points along the arterial circulation within the brain.

91
Q

Peripheral Aneurysms

A

Aneurysms occurring in the arteries of the lower limb are the most common peripheral aneurysms

92
Q

Aortic aneurysms pathogenesis

A

normal architecture becomes compromised, leading to progressive weakening and dilation. key initiating event is often the dysfunction and loss of vascular smooth muscle cells (VSMC), which are responsible for maintaining the extracellular matrix (ECM) and regulating vascular tone

93
Q

Chronic inflammation pathogenesis of arterial wall

A

originates from chronic damage to the aortic wall, primarily due to high blood pressure, oxidative stress and atherosclerosis leading to small injuries in the vessel wall.

94
Q

Oxidative stress pathogensis

A

damage smooth muscle cells (VSMCs) and extracellular matrix (ECM) proteins. stimulating even more immune cell recruitment and inflammation.

95
Q

Mechanical Stress causes

A

this inflammatory response persists indefinitely due to ongoing oxidative stress, mechanical strain, and defective cell clearance mechanisms. As a result, the aortic wall becomes progressively thinner and weaker.

96
Q

Cerebral Aneurysms pathogensis

A

frequently develop in areas where blood flow causes high wall shear stress, which is why they commonly occur at vessel bifurcations.

97
Q

aneurysms Clinical manifestations

A

silent until rupture, cerebral aneurysms present catastrophically with SAH, and peripheral aneurysms are prone to embolism and limb ischaemia.

97
Q

Peripheral aneurysms pathogensis

A

inflammation, ECM degradation and haemodynamic stress, but they also have unique contributors such as higher atherosclerotic involvement, localised mechanical stress, and genetic predisposition.

98
Q

Venous Pump

A

Muscle contractions in the calf and foot generate pressure that aids venous return, driving blood from the superficial to deep veins. Effective pumping depends on strong muscle contractions and functional valves

99
Q

Venous pressure varies with position, lying, sitting, standing, walking

A

lying- 15 mmHg
sitting- 55–75 mmHg
standing- 75–90 mmHg
walking- 40–55 mmHg

100
Q

Venous Valves:

A

These bicuspid structures direct blood from distal to proximal and from superficial to deep veins, preventing backflow

101
Q

Venous disorders

A

Vein-related problems may or may not be symptomatic and, when symptomatic, include a wide range of clinical signs that vary from minimal superficial venous dilation to chronic skin changes with ulcerationve

102
Q

venous disorders catogries

A

blockage from a blood clot (thrombosis) and inadequate venous drainage (insufficiency).

103
Q

venous disorders Aetiology

A

advancing age, female sex, family history of venous disease, ligamentous laxity, prolonged standing, increased body mass index, smoking, lower extremity trauma, prior venous thrombosis (ie, post-thrombotic) and certain hereditary conditions

104
Q

venous disorders Epidemiology

A

39% of the Australian population. The risk of chronic venous disease increases with age and has a 3 to 1 female predominance.

105
Q

Anatomic Changes of venous disorders

A

Valvular incompetence causes venous reflux and dilation. Chronic venous obstruction can lead to fibrosis and post-thrombotic syndrome

106
Q

Physiologic Changes of venous disorders

A

precapillary arterioles constrict
high venous pressure
endothelial dysfunction,
inflammation,
vessel wall remodeling,

107
Q

clinical manifestations of venous disorders

A

pain, leg heaviness, aching, swelling, skin dryness, tightness, itching, irritation, and muscle cramps
venous claudication - a severe deep pain and tightness
dilated veins, oedema, skin changes and/or venous ulcers.

108
Q

Thrombosis

A

commonly occur as deep vein thrombosis (DVT) of the lower extremity and pulmonary embolism (PE). The causes of venous thrombosis can be inherited or acquired.

109
Q

Thrombophlebitis

A

refers to inflammation of a vein associated with thrombus (blood clot) formation. It can occur in superficial veins (superficial thrombophlebitis) or deep veins (deep vein thrombophlebitis).

110
Q

Epidemiology of thrombosis

A

1 in 1000 people

111
Q

Aetiology of thrombosis

A

associated with conditions that increase the risk of clotting, including those that lead to decreased venous flow and pooling, abnormalities of coagulation or fibrinolysis and endothelial dysfunction

112
Q

Hypertension

A

high blood pressure, is where blood pressure is permanently higher than normal.

113
Q

Hypotension

A

decrease in systemic blood pressure below accepted low values.

114
Q

high systolic blood pressure

A

140 mmHg or more

115
Q

high diastolic blood pressure

A

90mmHg or more

116
Q

Epidemiology of high blood pressure in re to ses and IA

A

more common in lower ses c/to higher ses & first nations c/to non-indiginous australians

117
Q

Pathophysiology of high blood pressure

A

complex interactions between environmental and behavioural factors, genes, hormonal networks and multiple organ systems (renal, cardiovascular, and central nervous system)

118
Q

What Causes High Blood Pressure?

A

Blood pressure (BP) rises due to an imbalance in how the body regulates blood flow, fluid balance and blood vessel resistance.

119
Q

Vascular mechanisms

A

Changes in the structure and function of small and large arteries due to endothelial dysfunction play a key role in hypertension.

120
Q

Neural mechanisms in hypertension

A

In hypertension, the sympathetic nervous system (SNS) becomes overactive, leading to chronic vasoconstriction, increased heart workload and excessive sodium retention, which all contribute to a high BP

121
Q

Baroreceptor dysfunction

A

baroreceptors in aorta and carotid arteries detect BP changes and send signals to the brain to adjust SNS activity

In hypertension, baroreceptors become less sensitive (baroreflex dysfunction), so they fail to suppress SNS activity even when BP is high

122
Q

What are foam cells and how do they form?

A

Foam cells are lipid-laden macrophages that form when macrophages engulf oxidized LDL in the arterial wall.